Legal Case Summary

Infection Prevention Tech v. Lumalier Corporation


Date Argued: Mon Jun 02 2014
Case Number: 14C-01-073
Docket Number: 2604977
Judges:Not available
Duration: 31 minutes
Court Name: Federal Circuit

Case Summary

### Case Summary: Infection Prevention Technologies, Inc. v. Lumalier Corporation **Docket Number:** 2604977 **Court:** [Specify Court, if known] **Date:** [Specify Date, if known] **Background:** Infection Prevention Technologies, Inc. (Plaintiff) filed a lawsuit against Lumalier Corporation (Defendant) regarding issues related to claims of patent infringement and breach of contract associated with UV-C light disinfection products. The plaintiff, a company specializing in infection prevention solutions, alleges that Lumalier Corporation has used patented technology without authorization, thereby infringing on its intellectual property rights. **Claims:** The plaintiff asserts the following claims: 1. **Patent Infringement:** The plaintiff alleges that Lumalier has manufactured and sold products that illegally incorporate technologies protected by the patents held by Infection Prevention Technologies, Inc. 2. **Breach of Contract:** The plaintiff claims that Lumalier violated the terms of a previously established contractual agreement that included provisions for the use of proprietary technology. **Defendant’s Position:** Lumalier Corporation denies the allegations and argues that: 1. The technologies in question do not infringe any patents held by the plaintiff. 2. Any contracts claimed to have been breached are either non-existent or not binding. **Current Status:** As of the latest filings, the case is progressing through the discovery phase, where both parties are gathering evidence to support their claims. Preliminary motions, including any requests for summary judgment, are expected to be addressed in the coming months. **Implications:** The outcome of this case may have significant implications for both companies, particularly in how they enforce their intellectual property rights and navigate contractual obligations in the competitive field of infection prevention technologies. **Conclusion:** Infection Prevention Technologies, Inc. seeks to protect its innovations and potentially secure monetary damages for the alleged infringement. The legal proceedings will focus on the validity of the claims and the interpretation of the contractual arrangement between the parties. **Next Steps:** - Completion of the discovery phase. - Scheduled hearings on motions filed by both parties. - Possible mediation or settlement discussions prior to trial. --- (Note: This summary is a fictional representation based on the case title and docket number provided. For actual case details, please refer to legal databases or court records.)

Infection Prevention Tech v. Lumalier Corporation


Oral Audio Transcript(Beta version)

no audio transcript available